About: biomarkers

Expert: Europeans ‘effectively denied access’ to decisive cancer biomarkers

Biomarker testing holds the potential to revolutionise early diagnosis and prevention of cancer. But the EU has not yet managed to fully capitalise on these advances, according to health experts.